[Intuition Robotics in Marketplace Tech] Can robots make us less lonely?
An AI-powered robot named ElliQ is designed to have empathetic conversations with older adults to prevent the damaging effects of isolation. Listen...
Read MoreAuthor: OurCrowd
[Beyond Meat in Vegconomist] Europe Continues as Beyond Meat’s Strongest Market With Multiple Veganuary Activations
Beyond Meat’s vision is to be a global protein company helping the transition from animal to plant-based meat to address the climate crisis and animal welfare positively. Read...
Read More[ReWalk in GlobeNewsWire] ReWalk Robotics Expands Direct Sales Coverage to Canada
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that the Company is expanding its direct sales coverage to Canada. This expansion occurs as the result of the integration between the former ReWalk and AlterG commercial teams following the recent acquisition, which has resulted in a more extensive sales force with increased capacity. Read more...
Read More[Nexa3D in BusinessWire] Nexa3D completes acquisition of Essentium adding high-speed extrusion to its powerful additive manufacturing portfolio
VENTURA, Calif.–(BUSINESS WIRE)–Nexa3D, the ultrafast 3D printing leader, announced the successful completion of its acquisition of Essentium, a distinguished manufacturer of high-speed extrusion (HSE) 3D printers and materials. Nexa3D has rapidly emerged as an industry leader in industrial 3D printing, offering revolutionary production solutions to businesses across various sectors. Read...
Read More[Sequentify in PR Newswire] Sequentify Awarded Grant by Israel Innovation Authority for Infectious Disease Sequencing Panel
REHOVOT, Israel, Jan. 11, 2024 /PRNewswire/ — Sequentify, a company specializing in DNA sequencing technology, has been granted funding by the Israel Innovation Authority (IIA). This grant, contributing to a project totaling $1.3 million, supports the development of Sequentify’s targeted sequencing panel for infectious disease research. The panel aims to provide a culture-free, next-day solution for sequencing pathogens, focusing on pathogen diagnosis and antibiotic resistance surveillance. Read more...
Read More
